FRONTIER CAPITAL MANAGEMENT CO LLC
Position in ELAN — Elanco Animal Health Inc
CIK 351173
Boston, MA
Position in ELAN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$56,535,247
-$1,770,993 QoQ
Shares Held
2,362,526
-8.3% QoQ
Ownership
0.473%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 72.31061160808389.ToString("F0")%
Shared 0.ToString("F0")%
None 27.689388391916108.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FRONTIER CAPITAL MANAGEMENT CO LLC holds $206,678,536 across 3 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (27.4% of the industry book) .
All Filings in ELAN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $56,535,247 | 2,362,526 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $58,306,240 | 2,576,502 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $58,016,834 | 2,880,677 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,187,176 | 2,674,172 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $30,085,881 | 2,865,322 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,116,105 | 2,899,761 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $36,202,197 | 2,464,411 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $33,554,944 | 2,325,360 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $37,363,316 | 2,295,044 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $47,665,710 | 3,199,041 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $41,557,730 | 3,697,307 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,929,466 | 1,583,446 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,096,089 | 1,393,201 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||